LEADGENE
Language
EN
DE
JA
TW
Leadgene Leadgene
  • Products
    Products
    Product Types
    • Overview
    • GMP-Grade Products
    • IVD Products
    • Protein Engineering
    • Molecular Biology
    • Enzymes
    • Primary Antibodies
    • Secondary Antibodies
    • Recombinant Proteins
    • Cell Biology Reagent
    • ELISA Kits
    • Rapid Test Products
    • Buffers
    Resources
    • Chronic Kidney Disease
    • Nipah Virus
    • COVID-19
    • Cell Biology
    • Cardiovascular
    • Cancer
    • Dengue Virus
    • Enzyme
    • Epigenetics and Nuclear Signaling
    • Enterovirus
    • Flavivirus
    • Human Respiratory Syncytial Virus
    • Hepatitis B Virus
    • Influenza Virus
    • Isotype and Loading Controls
    • Immunology
    • Neuroscience
    • Organoid
    • Signal Transduction
    • Tags and Cell Markers
    • Zika Virus
    Close
  • Services
    Services

    Services

    We Innovate.
    We Explore.
    We Contribute.

    • Overview
    • Synthesis Service
    • Protein Service
    • Antibody Service
    • Development & Manufacture
    • Cell Line Development
    • Animal Model Analysis
    Close
  • Chronic Kidney Disease
    Chronic Kidney Disease

    Chronic Kidney Disease

    Hello, Kidney Health!

    • Health Education
    • Products
    Close
  • Quality
    Quality

    Quality

    Excellence in Our Profession
    Through Attention to Detail.

    • Quality Control
    Close
  • Support
    Support

    Support

    Bring You a New Vision of the World.

    • Scientific Knowledge
    • Literature
    • Protocol
    • FAQ
    Close
  • Company
    Company

    Company

    Details make our Profession.

    • About us
    • Contact Us
    • Distributors
    • News
    Close
  • Product Search
    COA Search
LEADGENE / Company

News

Latest News

2026.08.13
Leadgene Biomedical Secures Australian TGA Approval for Indoxyl Sulfate Test Kit, Addressing Blind Spots in Kidney Function Assessment—Taiwan's IVD R&D Takes the Global Stage
Leadgene Biomedical’s Indoxyl Sulfate (IS) ELISA Kit has received TGA approval in Australia as a Class 2 IVD medical device. By detecting toxic protein-bound uremic toxins missed by standard tests, this diagnostic tool addresses a major blind spot in kidney disease assessment while highlighting Taiwan’s expanding global presence in precision diagnostics.
2026.08.07
Leadgene Partners with BizCom Japan to Expand into the Japanese Life Sciences Market
Leadgene Partners with BizCom Japan to Expand into the Japanese Life Sciences Market
2026.07.24
Leadgene Biomedical's Indoxyl Sulfate ELISA Kit Receives IVD Approval in Australia
We are thrilled to share a major milestone for Leadgene! Our independently developed and manufactured in vitro diagnostic (IVD) reagent for kidney function assessment, Leadgene® Indoxyl Sulfate (IS) ELISA, has successfully completed medical device registration with the Australian Therapeutic Goods Administration (TGA) and was officially listed on the Australian Register of Therapeutic Goods (ARTG) on July 21, 2026.
1
/
3
2026.07.22

Leadgene Group Advances to BIO Asia, Building a One-Stop Biomedical R&D Service Chain to Connect Innovative Achievements and Accelerate Industrial Commercialization

2026.06.05

Leadgene Wins the 22nd Taiwan Golden Root Award, Recognized as Model for Deep Taiwan Roots and Global Expansion

2026.05.22

Breakthrough in Early CKD Diagnosis: Taiwanese Team Showcases Precision Indoxyl Sulfate ELISA Kit in Japan

2026.04.30

Powered by Biomedical R&D: Trustwell Pharmacy Opens in Tainan, Creating a New Hub for Community Health

2026.04.24

Leadgene Biomedical and Standard Biotechnology & Pharmaceutical Showcase Gut-Kidney Axis Care Solutions at the TSN Meeting

2026.04.22

From National Cancer Data to 200,000 Genomic Profiles: NBCT Lays the Foundation for Precision Medicine in Taiwan

2026.03.27

Leadgene Group Partners with DeepSense Biotech to Launch New AI-based Instrumentation Distribution Division

2026.03.12

Middle-aged Man Experiences Itching and Dizziness After Eating Shrimp: "Silent Toxin" Test Reveals Unexpected Kidney Damage

2026.03.06

Leadgene Biomedical Welcomes Lab Talent (Palm Science) as Official Distributor in Vietnam

2026.02.06

Leadgene Biomedical’s Nipah Virus Rapid Test Gains Global Attention Amid South Asia Outbreak

2026.01.02

New Partnership with ProBioscience Technologies in Singapore

2025.12.16

Brand Transformation Marks a New Chapter: CYTENA BPS Rebrands as Leadgene Biosolutions, Officially Joining Leadgene Biomedical Group

  • 1
  • 2
  • 3
  • Products
    • Overview
    • GMP-Grade Products
    • IVD Products
    • Protein Engineering
    • Molecular Biology
    • Enzymes
    • Primary Antibodies
    • Secondary Antibodies
    • Recombinant Proteins
    • Cell Biology Reagent
    • ELISA Kits
    • Rapid Test Products
    • Buffers
  • Services
    • Overview
    • Synthesis Service
    • Protein Service
    • Antibody Service
    • Development & Manufacture
    • Cell Line Development
    • Animal Model Analysis
  • Chronic Kidney Disease
    • Health Education
    • Products
  • Quality
    • Quality Control
  • Support
    • Scientific Knowledge
    • Literature
    • Protocol
    • FAQ
  • Company
    • About us
    • Contact Us
    • Distributors
    • News
  • Terms and Conditions
  • Privacy Policy
© 2026 LEADGENE BIOMEDICAL, INC. All rights reserved.
This site uses cookies as described in our Privacy Policy in order to improve your user experience and deliver customized advertising to you. Click “I Agree” to consent and continue.